Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Adam Cuker

Showing results (91-100 of 258) with videos related to

Pageof 26
Sort By:
Annals of Internal Medicine|October 18, 2021
Effectiveness and Safety of Direct Oral Anticoagulants Versus Warfarin in Patients With Valvular Atrial FibrillationGhadeer K Dawwas, Geoffrey D Barnes, Adam Cuker, et al.
Annals of Internal Medicine|February 23, 2026
The Risk for Bleeding in Patients With Atrial Fibrillation From Concomitant Use of Apixaban or Rivaroxaban With Diltiazem Compared With MetoprololGhadeer K Dawwas, James D Lewis, Yacob G Tedla, et al.
Journal of the American College of Cardiology|September 13, 2014
Laboratory measurement of the anticoagulant activity of the non-vitamin K oral anticoagulantsAdam Cuker, Deborah M Siegal, Mark A Crowther, et al.
Annals of Internal Medicine|December 6, 2021
Risk for Recurrent Venous Thromboembolism and Bleeding With Apixaban Compared With Rivaroxaban: An Analysis of Real-World DataGhadeer K Dawwas, Charles E Leonard, James D Lewis, et al.
Blood|September 20, 2012
Predictive value of the 4Ts scoring system for heparin-induced thrombocytopenia: a systematic review and meta-analysisAdam Cuker, Phyllis A Gimotty, Mark A Crowther, et al.
Thrombosis and Haemostasis|July 29, 2010
Interlaboratory variation in heparin monitoring: Lessons from the Quality Management Program of Ontario coagulation surveysAdam Cuker, Anne Raby, Karen A Moffat, et al.
Thrombosis Research|August 18, 2024
Examining postpartum anticoagulation practices: An international survey of healthcare providersEvangelia Vlachodimitropoulou, Marc Carrier, Kinga Malinowski, et al.
Journal of Thrombosis and Haemostasis : JTH|March 8, 2025
How to deal with interference on heparin anti-Xa activity caused by oral factor FXa inhibitors: communication from the ISTH SSC Subcommittee on Control of AnticoagulationNicolas Gendron, Adam Cuker, Robert C Gosselin, et al.
Blood Advances|June 26, 2026
ASH Clinical Practice Guidelines - Evaluation of discordance between certainty of evidence and strength of recommendationsSamantha A Hershenfeld, Robert Kunkle, Menaka Pai, et al.
American Journal of Medical Genetics. Part A|September 16, 2004
Candidate locus for Gilles de la Tourette syndrome/obsessive compulsive disorder/chronic tic disorder at 18q22Adam Cuker, Matthew W State, Robert A King, et al.
Pageof 26

Showing results (91-100 of 258) with videos related to

Sort By:
Pageof 26
Annals of Internal Medicine|October 18, 2021
Effectiveness and Safety of Direct Oral Anticoagulants Versus Warfarin in Patients With Valvular Atrial FibrillationGhadeer K Dawwas, Geoffrey D Barnes, Adam Cuker, et al.
Annals of Internal Medicine|February 23, 2026
The Risk for Bleeding in Patients With Atrial Fibrillation From Concomitant Use of Apixaban or Rivaroxaban With Diltiazem Compared With MetoprololGhadeer K Dawwas, James D Lewis, Yacob G Tedla, et al.
Journal of the American College of Cardiology|September 13, 2014
Laboratory measurement of the anticoagulant activity of the non-vitamin K oral anticoagulantsAdam Cuker, Deborah M Siegal, Mark A Crowther, et al.
Annals of Internal Medicine|December 6, 2021
Risk for Recurrent Venous Thromboembolism and Bleeding With Apixaban Compared With Rivaroxaban: An Analysis of Real-World DataGhadeer K Dawwas, Charles E Leonard, James D Lewis, et al.
Blood|September 20, 2012
Predictive value of the 4Ts scoring system for heparin-induced thrombocytopenia: a systematic review and meta-analysisAdam Cuker, Phyllis A Gimotty, Mark A Crowther, et al.
Thrombosis and Haemostasis|July 29, 2010
Interlaboratory variation in heparin monitoring: Lessons from the Quality Management Program of Ontario coagulation surveysAdam Cuker, Anne Raby, Karen A Moffat, et al.
Thrombosis Research|August 18, 2024
Examining postpartum anticoagulation practices: An international survey of healthcare providersEvangelia Vlachodimitropoulou, Marc Carrier, Kinga Malinowski, et al.
Journal of Thrombosis and Haemostasis : JTH|March 8, 2025
How to deal with interference on heparin anti-Xa activity caused by oral factor FXa inhibitors: communication from the ISTH SSC Subcommittee on Control of AnticoagulationNicolas Gendron, Adam Cuker, Robert C Gosselin, et al.
Blood Advances|June 26, 2026
ASH Clinical Practice Guidelines - Evaluation of discordance between certainty of evidence and strength of recommendationsSamantha A Hershenfeld, Robert Kunkle, Menaka Pai, et al.
American Journal of Medical Genetics. Part A|September 16, 2004
Candidate locus for Gilles de la Tourette syndrome/obsessive compulsive disorder/chronic tic disorder at 18q22Adam Cuker, Matthew W State, Robert A King, et al.
Pageof 26